Metabolic Sleep

Semaglutide reaches its highest plasma concentration 1-3 days after each weekly injection. This pharmacokinetic peak — called Cmax — drives the intensity of side effects including nausea, brain arousal, and gastrointestinal disruption, all of which interfere with sleep. The result is a predictable weekly pattern: your worst night of sleep falls within 24-48 hours of […]

During adequate sleep, leptin rises and suppresses hunger while ghrelin stays low. When sleep is restricted — even for two nights — leptin drops by 18% and ghrelin rises by 28% (Spiegel et al., 2004). This hormonal reversal coincides with the 2-4am cortisol rise and the overnight blood sugar nadir. The combination of suppressed satiety,

Yes — through a specific biochemical pathway. When semaglutide suppresses appetite enough to substantially reduce food intake, the brain receives less tryptophan, an amino acid required to produce serotonin and melatonin. Both neurotransmitters are essential for sleep initiation and maintenance. Caloric restriction at the level many GLP-1 users experience has been shown to reduce plasma

GLP-1 receptor agonists like semaglutide interact with two neurotransmitter systems that regulate dreaming: serotonin neurons in the dorsal raphe nucleus, which gate REM sleep onset, and dopamine circuits in the nucleus accumbens, which modulate dream intensity. These interactions may explain why some users report unusually vivid or disturbing dreams, particularly during dose increases — though

Semaglutide suppresses appetite so effectively that many users eat significantly less than their body needs. When evening food intake drops too low, blood glucose falls during the early morning hours. The brain detects this glucose drop as an emergency and triggers a counter-regulatory surge of cortisol and adrenaline — stress hormones designed to raise blood

GLP-1 receptor agonists activate orexin neurons in the lateral hypothalamus — the brain cells that drive wakefulness. Semaglutide, the active ingredient in Ozempic and Wegovy, binds the same GLP-1 receptors studied in preclinical models. At the same time, reduced caloric intake from appetite suppression creates physical fatigue. The result is a paradox: your body is

Yes — and the relationship runs in both directions. Fatty liver (NAFLD/MASLD) independently disrupts sleep, while poor sleep independently causes fatty liver. People with NAFLD fall asleep 17 minutes later and sleep 54 minutes less per night than healthy controls, with daytime sleepiness tracking liver enzyme elevation and fibrosis stage. Genetic instrumental-variable evidence indicates that